EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62016TA0276
Case T-276/16: Judgment of the General Court of 15 September 2017 — Viridis Pharmaceutical v EUIPO — Hecht-Pharma (Boswelan) (EU trade mark — Revocation proceedings — EU word mark Boswelan — Declaration of revocation — Article 51(1)(a) of Regulation (EC) No 207/2009 — No genuine use of the trade mark — No proper reasons for non-use)
Case T-276/16: Judgment of the General Court of 15 September 2017 — Viridis Pharmaceutical v EUIPO — Hecht-Pharma (Boswelan) (EU trade mark — Revocation proceedings — EU word mark Boswelan — Declaration of revocation — Article 51(1)(a) of Regulation (EC) No 207/2009 — No genuine use of the trade mark — No proper reasons for non-use)
Case T-276/16: Judgment of the General Court of 15 September 2017 — Viridis Pharmaceutical v EUIPO — Hecht-Pharma (Boswelan) (EU trade mark — Revocation proceedings — EU word mark Boswelan — Declaration of revocation — Article 51(1)(a) of Regulation (EC) No 207/2009 — No genuine use of the trade mark — No proper reasons for non-use)
OJ C 369, 30.10.2017, p. 12–12
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
- Date of document:
- 15/09/2017
- Date lodged:
- 30/05/2016
- Author:
- General Court
- Form:
- Judicial information
- Authentic language:
- German
- Type of procedure:
- Action for annulment - unfounded
- Link
- Select all documents mentioning this document
- Case affecting:
-
- Related EU case-law document 62016TJ0276
- Instruments cited in case law:
- Link
- EUROVOC descriptor:
|
30.10.2017 |
EN |
Official Journal of the European Union |
C 369/12 |
Judgment of the General Court of 15 September 2017 — Viridis Pharmaceutical v EUIPO — Hecht-Pharma (Boswelan)
(Case T-276/16) (1)
((EU trade mark - Revocation proceedings - EU word mark Boswelan - Declaration of revocation - Article 51(1)(a) of Regulation (EC) No 207/2009 - No genuine use of the trade mark - No proper reasons for non-use))
(2017/C 369/16)
Language of the case: German
Parties
Applicant: Viridis Pharmaceutical Ltd (Tortola, British Virgin Isles) (represented by: C. Spintig, S. Pietzcker and M. Prasse, lawyers)
Defendant: European Union Intellectual Property Office (represented by: S. Hanne, acting as Agent)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Hecht-Pharma GmbH (Hollnseth, Germany) (represented by: C. Sachs and J. Sachs, lawyers)
Re:
Action brought against the decision of the Fifth Board of Appeal of EUIPO of 29 February 2016 (Case R 2837/2014-5), relating to revocation proceedings between Hecht-Pharma and Viridis Pharmaceutical.
Operative part of the judgment
The Court:
|
1. |
Dismisses the action; |
|
2. |
Orders Viridis Pharmaceutical Ltd to pay the costs. |
